ECI
EXAS

EFG Capital International’s Exact Sciences EXAS Stock Holding History

EFG Capital International’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		$287K Buy
+3,053
New +$238K 0.07% 128

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

EFG Capital International's EXAS Position: Q2 2023 in Review

EFG Capital International opened a new position in Exact Sciences (EXAS) in Q2 2023: 3,053 shares worth $287K. The stake represents 0.07% of the portfolio and ranks #128 among its holdings.

652 funds tracked by Wall St. Rank hold EXAS as of Q2 2023.

  • EFG Capital International held 3,053 shares of Exact Sciences worth $287K as of Q2 2023.
  • Exact Sciences was a new EFG Capital International position in Q2 2023.
  • Exact Sciences made up 0.07% of EFG Capital International's portfolio in Q2 2023, its #128 holding.
  • 652 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2023.

Based on EFG Capital International's 13F filing for Q2 2023, filed 2 Aug 2023.